Sign in to view content

Year 1 Time to Mobility Test Completion in a Voretigene Neparvovec-rzyl Trial in Subjects With RPE65 Mutation–Associated Inherited Retinal Disease

Julia A. Haller, MD

Video
Published 2018

Related

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Canadian Treat-and-Extend Analysis Trial With Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2018
Initial Experience With a Novel Hypersonic Vitrectomy Device for Vitreoretinal Surgery
Kevin J. Blinder, MD, FASRS
Annual Meeting Talks
2018

Category: Inherited retinal diseases

See more